Cargando…
A Case Report for Acute Myopericarditis After NVX-CoV2373 (Novavax(®)) COVID-19 Vaccination
Post-vaccination myocarditis after administration of the NVX-CoV2373 coronavirus disease 2019 (COVID-19) vaccine has been reported in a limited population. We report the first biopsy-proven case of myopericarditis after administration of second dose of NVX-CoV2373 COVID-19 vaccine (Novavax®) in Kore...
Autores principales: | Kim, Hyung Yoon, Cho, Jae Yeong, Yoon, Hyun Ju, Choi, Yoo-Duk, Ahn, Youngkeun, Jeong, Myung Ho, Cho, Jeong Gwan, Kim, Kye Hun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424696/ https://www.ncbi.nlm.nih.gov/pubmed/36038960 http://dx.doi.org/10.3346/jkms.2022.37.e265 |
Ejemplares similares
-
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
por: Bhiman, Jinal N., et al.
Publicado: (2023) -
Myopericarditis Associated with the Novavax COVID-19 Vaccine (NVX-CoV2373): A Retrospective Analysis of Individual Case Safety Reports from VigiBase
por: Macías Saint-Gerons, Diego, et al.
Publicado: (2023) -
Myopericarditis following both BNT162b2 and NVX-CoV2373
por: Ahmad, Saima, et al.
Publicado: (2022) -
A Case of Acute Eosinophilic Myopericarditis Presenting with Cardiogenic Shock and Normal Peripheral Eosinophil Count
por: Sohn, Il Suk, et al.
Publicado: (2006) -
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
por: Heath, Paul T., et al.
Publicado: (2021)